SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Speciality rises on filing for patent application for novel process for Coumarin

10 Jul 2017 Evaluate

Omkar Speciality Chemicals is currently trading at Rs. 99.35, up by 0.85 points or 0.86% from its previous closing of Rs. 98.50 on the BSE.

The scrip opened at Rs. 98.50 and has touched a high and low of Rs. 101.50 and Rs. 97.05 respectively. So far 60,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 102.50 on 07-Jul-2017 and a 52 week low of Rs. 59.69 on 09-Nov-2016.

Last one week high and low of the scrip stood at Rs. 102.50 and Rs. 77.00 respectively. The current market cap of the company is Rs. 204.44 crore.

The promoters holding in the company stood at 41.01%, while Institutions and Non-Institutions held 3.58% and 55.40% respectively.

Omkar Speciality Chemicals has applied for grant of patent for a novel catalytic process for preparation of Coumarin to obtain high yield and superfine quality product. This product is widely consumed in fragrances and perfumery industries. The company is in advance level negotiations for tie up with a global leading consumers of this products.

Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.


Omkar SpecialityChem Share Price

4.30 0.10 (2.38%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×